Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOPHA: Long-term Oxygen Therapy in PAH and CTEPH
NCT04207593Phase 2Completed
- Sponsor
- Heidelberg University
- Start
- Apr 2019
- Primary completion
- Jan 2023
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 2 trial of oxygen in pulmonary arterial hypertension (PAH), chronic thromboembolic pulmonary hypertension (CTEPH), sponsored by Heidelberg University. Started Apr 2019; status: completed.
02
Drugs
oxygen
03
Conditions
pulmonary arterial hypertension (PAH)chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on NCT04207593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04207593.